{"url_path":"/sec/ogn/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1821825/0001193125-26-178718-index.html","accession_number":"0001193125-26-178718","cik":"0001821825","ticker":"OGN","issuer_name":"Organon & Co.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1821825/0001193125-26-178718-index.html","primary_entity_key":"0001821825","primary_entity_name":"Organon & Co."},"word_count":204,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) The following items are filed as exhibits to this Current Report on Form 8-K.\n\n \n\nExhibit No.\n\n  \n\nDescription of Exhibits\n\n2.1*\n  \n[Agreement and Plan of Merger, dated as of April 26, 2026, by and among Organon & Co., Sun Pharmaceutical Holdings USA, Inc., Sun Pharma America, Inc. and, solely for the purposes of certain Covered Provisions of the Merger Agreement (as defined therein), Sun Pharmaceutical Industries Limited, Sun Pharma Canada Inc. and Sun Pharma (Netherlands) B.V.](d38652dex21.htm)\n\n99.1\n  \n[Joint Press Release, dated April 26, 2026.](d38652dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n*\n\nSchedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act, for any schedules so furnished.\n\n \n\nSignature\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nOrganon & Co.\n\n(Registrant)\n\nBy:\n \n\n/s/ Kirke Weaver\n\nName:\n \nKirke Weaver\n\nTitle:\n \nGeneral Counsel & Corporate Secretary\n\nDate: April 26, 2026"}